Page 102 - Biomarkers for risk stratification and guidance in heart failure
P. 102
CHAPTER 5
Risk Stratification With the Use of Serial N-Terminal Pro- B-Type Natriuretic Peptide Measurements During Admission and Early After Discharge in Heart Failure Patients: Post Hoc Analysis of the PRIMA Study
Luc W. Eurlings, MD,1 Sandra Sanders-Van Wijk, MD,1 Dave J.W. Van Kraaij, MD, PhD,2 Roland Van Kimmenade, MD, PhD,1,3 Joan G. Meeder, MD, PhD,4 Otto Kamp, MD, PhD,5 Marja P. Van Dieijen-Visser, MD, PhD,6 Jan G.P. Tijssen, MD, PhD,7 Hans-Peter Brunner-La Rocca, MD, PhD,1 and Yigal M. Pinto, MD, PhD7
From the 1Department of Cardiology, Maastricht University Medical Center, CARIM, Maastricht, The Netherlands; 2Department of Cardiology, Orbis Medical Center, Sittard, The Netherlands; 3Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands; 4Department of Cardiology,
Viecuri Medical Center, Venlo, The Netherlands; 5Department of Cardiology, VU Medical Center, Amsterdam, The Netherlands; 6Department of Clinical Chemistry, Maastricht University Medical Center, Maastricht, The Netherlands and 7Department of Cardiology, Heart Failure Research Center, Academic Medical Center, Amsterdam, The Netherlands.
Journal of Cardiac Failure, 2014 Dec; 20 (12): 881-90
